Disc Medicine rallies $90m Series B
Disc Medicine, a developer of treatments for serious and debilitating hematologic diseases, has raised $90 million in Series B financing.
Disc Medicine, a developer of treatments for serious and debilitating hematologic diseases, has raised $90 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination